載入...
Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension
BACKGROUND: Despite the increased risk for pulmonary hypertension in children with Down syndrome, the response to treatment with targeted therapies for pulmonary hypertension in these patients is not well characterized. The Sildenafil in Treatment-naive children, Aged 1–17 years, with pulmonary arte...
Na minha lista:
| 發表在: | BMC Cardiovasc Disord |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5496590/ https://ncbi.nlm.nih.gov/pubmed/28676038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-017-0569-3 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|